Therapeutic drug monitoring of anti-TNF drugs: an overview of applicability in daily clinical practice in the era of treatment with biologics in juvenile idiopathic arthritis (JIA)
Abstract Background Anti-tumor necrosis factor (TNF) drugs have improved the prognosis for juvenile idiopathic arthritis (JIA) significantly. However, evidence for individual treatment decisions based on serum anti-TNF drug levels and the presence of anti-drug antibodies (ADAbs) in children is scarc...
Saved in:
Main Authors: | A. Nassar-Sheikh Rashid (Author), D. Schonenberg-Meinema (Author), S. C. Bergkamp (Author), S. Bakhlakh (Author), A. de Vries (Author), T. Rispens (Author), T. W. Kuijpers (Author), G. Wolbink (Author), J. M. van den Berg (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experiences, perspectives and expectations of adolescents with juvenile idiopathic arthritis regarding future work participation; a qualitative study
by: E. Charlotte van Gulik, et al.
Published: (2020) -
Anakinra in systemic juvenile idiopathic arthritis (soJIA) non responsive to antiTNF
by: Pontikaki I, et al.
Published: (2008) -
Efficacy of a second TNF blocker, when the first one failed, in patients with juvenile idiopathic arthritis (JIA)
by: Salmaso A, et al.
Published: (2008) -
Mandibular condyle destruction in juvenile idiopathic arthritis (JIA)
by: Zak M, et al.
Published: (2008) -
Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
by: Alpigiani MG, et al.
Published: (2008)